Clinical Misconceptions Dispelled by Epidemiological Research (Q40430646)

20 September 2017

1 reference

title

Clinical misconceptions dispelled by epidemiological research (English)

1 reference

20 September 2017

Clinical Misconceptions Dispelled by Epidemiological Research (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

25 May 2024

1 reference

W. B. Kannel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586324

25 May 2024

language of work or name

English

0 references

publication date

1 December 1995

1 reference

full work available at URL

20 September 2017

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.11.3350

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

25 May 2024

1 reference

20 September 2017

92

1 reference

20 September 2017

11

1 reference

20 September 2017

3350-3360

1 reference

The quality of epidemiological data in coronary heart disease and atherosclerosis

20 September 2017

1

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Bad science and social penalties

25 May 2024

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Limitations of the epidemiological method in coronary heart disease

25 May 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

25 May 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Coronary heart disease in the Framingham study

25 May 2024

6

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

A prospective study of degenerative cardiovascular disease in Albany: report of three years' experience. I. Ischemic heart disease

25 May 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Measuring the risk of coronary heart disease in adult population groups. The clinical status of a population group in Los Angeles under observation for two to three years

25 May 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Risk factors and coronary heart disease—facts or fancy?

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Dietary cholesterol, plasma cholesterol and coronary heart disease

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The therapeutic challenge of systolic hypertension.

25 May 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Blood Pressure and Risk of Coronary Heart Disease: The Framingham Study

25 May 2024

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

25 May 2024

22

18

629

1970

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Lipid profile and the potential coronary victim

25 May 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

25 May 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Ischemic heart disease, atherosclerosis, and longevity.

25 May 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

25 May 2024

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study

25 May 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Efficacy of lipid profiles in prediction of coronary disease

25 May 2024

32

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Cardiovascular Complications in Diabetics

25 May 2024

34

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

25 May 2024

35

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Role of diabetes in congestive heart failure: the Framingham study

25 May 2024

36

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

25 May 2024

37

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: The Framingham Study

25 May 2024

38

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The New England Journal of Medicine

25 May 2024

43

332

287

1995

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

25 May 2024

44

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study

25 May 2024

46

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies

25 May 2024

47

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The influence of obesity on health (second of two parts).

25 May 2024

50

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

W. O. Atwater memorial lecture: overweight, obesity, coronary heart disease and mortality.

25 May 2024

51

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Impact of age on weight goals

25 May 2024

52

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Acta medica Scandinavica. Supplementum

25 May 2024

53

723

23

1988

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years

25 May 2024

54

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Annals of Internal Medicine

25 May 2024

55

110

864

1989

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics.

25 May 2024

56

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study

25 May 2024

57

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Update on fibrinogen as a cardiovascular risk factor

25 May 2024

58

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The New England Journal of Medicine

25 May 2024

59

34

501

1984

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Plasma fibrinogen and coronary risk factors: the Scottish Heart Health Study

25 May 2024

61

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

25 May 2024

62

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The leukocyte count as a predictor of myocardial infarction

25 May 2024

64

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Leukocyte count, smoking, and myocardial infarction

25 May 2024

65

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Leukocyte counts and coronary heart disease in a Japanese cohort

25 May 2024

66

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality.

25 May 2024

67

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Leukocyte count and risk of major coronary heart disease events

25 May 2024

68

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Coronary heart-disease and physical activity of work

25 May 2024

70

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The relationship of reported coronary heart disease mortality to physical activity of work

25 May 2024

72

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Physique of London busmen; epidemiology of uniforms

25 May 2024

73

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Is exercise beneficial--or hazardous--to your heart?

25 May 2024

74

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The health benefits of exercise. A critical reappraisal

25 May 2024

75

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Physical activity as an index of heart attack risk in college alumni

25 May 2024

76

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

A meta-analysis of physical activity in the prevention of coronary heart disease

25 May 2024

77

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study

25 May 2024

80

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Left ventricular hypertrophy and mortality--results from the Framingham Study

25 May 2024

81

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

25 May 2024

82

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Epidemiologic features of chronic atrial fibrillation: the Framingham study

25 May 2024

84

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

25 May 2024

85

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Coronary heart disease and atrial fibrillation: the Framingham Study

25 May 2024

86

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Idiopathic atrial fibrillation

25 May 2024

87

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study

25 May 2024

88

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The natural history of lone atrial fibrillation. A population-based study over three decades

25 May 2024

89

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Atrial fibrillation and stroke in elderly hospitalized patients

25 May 2024

90

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Randomized trials of warfarin for atrial fibrillation

25 May 2024

91

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study

25 May 2024

92

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Natural history of angina pectoris in the Framingham study. Prognosis and survival

25 May 2024

94

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women

25 May 2024

95

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Sudden death: lessons from subsets in population studies

25 May 2024

96

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The treatment of recurrent cerebrovascular symptoms and the question of "vasospasm"

25 May 2024

98

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Blood pressure, stroke, and coronary heart disease

25 May 2024

100

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The Natural History of Congestive Heart Failure: The Framingham Study

25 May 2024

101

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Cardiac failure and sudden death in the Framingham Study

25 May 2024

102

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Prevalence of intermittent claudication and its effect on mortality

25 May 2024

105

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

25 May 2024

106

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

The multifactorial aetiology of coronary heart disease: a dangerous delusion

25 May 2024

107

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.11.3350

25 May 2024

Identifiers

1 reference

20 September 2017

1 reference